Skip to main content

Table 2 Characteristics of HIV-1 negative controls and HIV-1 infected patients with colorectal tissue biopsies

From: Activation-induced pyroptosis contributes to the loss of MAIT cells in chronic HIV-1 infected patients

HIV status/patient ID Gender Age (years) Comorbidities CD4+ T cell count (cells/μl) Plasma viral load (copies/ml) cART regimen
HIV-1 negative controls (n = 7)
 0057 M 49 Colon polyp NA NA NA
 7403 M 48 Rectum polyp NA NA NA
 7435 M 55 Colon polyp NA NA NA
 7559 F 70 Colon polyp NA NA NA
 7582 F 50 Colon polyp NA NA NA
 7590 M 46 Colon polyp NA NA NA
 7894 F 54 Colon polyp NA NA NA
HIV-1 infected patients (n = 7)
 0118 F 40 Colon cancer 435  < LOD 3TC/AZT/EFV
 0128 M 55 Rectum cancer 86 693,800 Untreated
 0129 F 61 Colon cancer 246  < LOD 3TC/AZT/EFV
 0288 M 36 Colon cancer 119  < LOD 3TC/AZT/NVP
 0293 M 63 Colon cancer 327 172,500 Untreated
 0295 M 31 Colon cancer 913  < LOD 3TC/EFV/TDF
 0316 F 53 Colon cancer 338  < LOD 3TC/EFV/TDF
  1. HIV human immunodeficiency virus, cART combined antiretroviral therapy, NA not applicable, < LOD below the limit of detection of 80 copies/ml, 3TC lamivudine, AZT azidothymidine, EFV efavirenz, NVP nevirapine, TDF tenofovirdisoproxil